antimicrobial resistance
Diasorin Submits Gram-Negative Bacteria Panel for FDA 510(k) Clearance
The firm's Gram-negative blood culture assay is used to identify bacterial pathogens and drug resistances, with results within two hours of a Gram stain.
Cepheid, Fleming Initiative Partner to Address Antimicrobial Resistance
The partnership will include collaborative research with a focus on expanding the use of in vitro diagnostics to support antimicrobial stewardship programs.
The Baltimore-based firm is developing multiplex molecular tests for sexually transmitted disease identification and drug susceptibility characterization.
New York State Awards $3M to Researchers for Infectious Disease Tool Innovations
Teams from Rover Diagnostics, Mount Sinai, Columbia University, and Niagara University are the third round of awardees of the state’s Biodefense Commercialization Fund.
Diasorin Nabs FDA De Novo Clearance for Candida Auris Assay
The firm said that the test can be used to help prevent and control the spread of the fungal pathogen, which is a common cause of hospital-acquired infections.